Thrivent Financial for Lutherans’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-74,625
| Closed | -$405K | – | 2514 |
|
|
2024
Q4 | $405K | Buy |
74,625
+38,876
| +109% | +$211K | ﹤0.01% | 2330 |
|
|
2024
Q3 | $258K | Hold |
35,749
| – | – | ﹤0.01% | 2425 |
|
|
2024
Q2 | $389K | Buy |
+35,749
| New | +$389K | ﹤0.01% | 2312 |
|
|
2023
Q2 | – | Sell |
-30,567
| Closed | -$1.28M | – | 2528 |
|
|
2023
Q1 | $1.28M | Hold |
30,567
| – | – | ﹤0.01% | 1625 |
|
|
2022
Q4 | $1.17M | Buy |
30,567
+24,440
| +399% | +$932K | ﹤0.01% | 1628 |
|
|
2022
Q3 | $240K | Buy |
+6,127
| New | +$240K | ﹤0.01% | 2299 |
|
|
2022
Q2 | – | Sell |
-6,127
| Closed | -$203K | – | 2502 |
|
|
2022
Q1 | $203K | Sell |
6,127
-41,012
| -87% | -$1.36M | ﹤0.01% | 2447 |
|
|
2021
Q4 | $2.01M | Buy |
+47,139
| New | +$2.01M | ﹤0.01% | 1401 |
|
|
2021
Q2 | – | Sell |
-19,883
| Closed | -$1.49M | – | 2545 |
|
|
2021
Q1 | $1.49M | Sell |
19,883
-17,622
| -47% | -$1.32M | ﹤0.01% | 1600 |
|
|
2020
Q4 | $3.24M | Sell |
37,505
-10,721
| -22% | -$927K | 0.01% | 1048 |
|
|
2020
Q3 | $2.95M | Sell |
48,226
-928
| -2% | -$56.7K | 0.01% | 975 |
|
|
2020
Q2 | $2.04M | Buy |
49,154
+131
| +0.3% | +$5.45K | 0.01% | 1045 |
|
|
2020
Q1 | $1.41M | Sell |
49,023
-18,556
| -27% | -$533K | 0.01% | 1116 |
|
|
2019
Q4 | $4.88M | Buy |
67,579
+7,265
| +12% | +$524K | 0.01% | 741 |
|
|
2019
Q3 | $8.46M | Buy |
60,314
+1,542
| +3% | +$216K | 0.03% | 552 |
|
|
2019
Q2 | $10.8M | Buy |
58,772
+333
| +0.6% | +$61K | 0.03% | 491 |
|
|
2019
Q1 | $9.3M | Buy |
58,439
+576
| +1% | +$91.6K | 0.03% | 497 |
|
|
2018
Q4 | $5.54M | Buy |
57,863
+38,745
| +203% | +$3.71M | 0.02% | 589 |
|
|
2018
Q3 | $2.7M | Sell |
19,118
-2,319
| -11% | -$328K | 0.01% | 791 |
|
|
2018
Q2 | $3.36M | Buy |
21,437
+115
| +0.5% | +$18K | 0.01% | 740 |
|
|
2018
Q1 | $3.43M | Buy |
21,322
+272
| +1% | +$43.8K | 0.01% | 734 |
|
|
2017
Q4 | $3.47M | Buy |
+21,050
| New | +$3.47M | 0.01% | 739 |
|